Pfizer Inc. (NYSE: PFE) today announced that the U.S. Food and Drug Administration (FDA) has approved BRAFTOVI® (encorafenib) in combination with ...

U.S. FDA Approves Pfizer’s BRAFTOVI® Combination Regimen as First-Line Treatment of BRAF V600E-Mutant Metastatic Colorectal Cancer ...

Detroit-based Wayne State University's Barbara Ann Karmanos Cancer Institute is the first facility in the world to prescribe a new at-home liver cancer treatment.

Ready to make strategic alliances? Solstice ushers in Capricorn season today, highlighting functional partnerships, goal-oriented collaboration, and formalized agreements. Whether personal or ...